Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With HFpEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction
J Am Coll Cardiol 2022 Mar 29;79(12)1129-1137, JP Ferreira, J Butler, F Zannad, G Filippatos, E Schueler, D Steubl, C Zeller, JL Januzzi, S Pocock, M Packer, SD AnkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.